As of Apr 28
| -0.2008 / -2.53%|
The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +190.32% increase from the last price of 7.75.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.